European Medicines Agency (EMA) Updates For patients in Europe, access to new medications is governed by the European Medicines Agency (EMA)
Regulatory bodies have states this rat-only pathway shouldn't be used to judge human risk
Your provider can help you choose between oral and injection forms based on your genetic profile, previous medication tolerance, and personal preference
If using WEGOVY: If you have diabetes mellitus and are on glycemic lowering therapy: The risk of hypoglycemia may be increased with this product
There is also growing evidence that the activation of ferroptosis contributes to the anticancer treatment of several forms of drug-resistant solid tumors, such as liver cancer, lung cancer, breast cancer, pancreatic cancer, gastrointestinal cancers, which undoubtedly makes that the combination of System X c /GSH/GPX4 axis-based ferroptosis inducers with chemotherapeutic agents may become a new strategy for the treatment of drug-resistant solid tumors
Patients should always communicate with their provider about any persistent symptoms
